Weiss Asset Management’s Tourmaline Bio TRML Stock Holding History

Weiss Asset Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,387	Closed	-$784K	–	844
2025 Q3	$784K	Buy	+16,387	New	+$454K	0.01%	386

Weiss Asset Management's TRML Position: Q4 2025 in Review

Weiss Asset Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 16,387 shares — an estimated $784K sold.

Weiss Asset Management first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $784K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Weiss Asset Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Weiss Asset Management sold 16,387 Tourmaline Bio shares in Q4 2025, an estimated $784K.
Weiss Asset Management first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Weiss Asset Management's Tourmaline Bio position peaked at $784K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Weiss Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.